Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Thyroid Neoplasms 8Carcinoma, Medullary 6Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 3Thyroid Cancer, Papillary 2Familial medullary thyroid carcinoma 2Adenocarcinoma, Follicular 2Thyroid cancer, medullary 1Thyroid Diseases 1Thyroid Carcinoma, Anaplastic 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Neoplasms 1Neoplasm Metastasis 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Locally Advanced Thyroid Gland Carcinoma 1Esthesioneuroblastoma, Olfactory 1Differentiated Thyroid Cancer 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

vandetanib 2Sorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Familial medullary thyroid carcinoma × vandetanib × Head & Neck × Clear all
NCT00410761 2025-09-24

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

Sanofi

Phase 3 Completed
331 enrolled 15 charts
EndocrineHead & Neck

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

NCT00358956 2017-01-30

A Study To Assess ZD6474 (ZACTIMAâ„¢) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Sanofi

Phase 2 Completed
19 enrolled 10 charts
EndocrineHead & Neck

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡